Buruli ulcer: Evaluation of its medical and surgical management at the Allada (Benin) Screening and Treatment Center, 2010-2014

• Published in: Médecine et santé tropicales (Montrouge, France) Vol. 29; no. 4; p. 402
• Main Authors: Degboe, B, Sopoh, G E, Alimi, M, Koudoukpo, C, Akpadjan, F, Agbéssi, N, Johnson, R C, Adégbidi, H, Atadokpèdé, F
• Format: Journal Article
• Language: English; French
• Published: France 01.11.2019
• Subjects: Benin; healing; surgical treatment; medical treatment; Buruli ulcer
• ISSN: 2261-2211
• DOI: 10.1684/mst.2019.0929

The objective of our study was to evaluate the medico-surgical management of Buruli ulcer (BU) in the BU Screening and Treatment Center (CDTUB) of Allada in Benin. This retrospective and descriptive study retrospectively reviewed records of patients seen from 2010 to 2014 at the CDTUB of Allada. It included patients diagnosed with BU according to WHO epidemiological and clinical criteria as well as laboratory results and who were treated according to WHO medical and surgical recommendations. In all, 274 patients were diagnosed and treated, 57.7% of them children younger than 15 years. Ulcerative lesions (189, 69%) and WHO category II lesions (144, 52.5%) predominated. All patients received dual antibiotic therapy and 43.4% (119) underwent surgery as well. Category III lesions and multifocal lesions required more surgery, whereas most category I lesions healed under medical treatment. The overall rate of healing was 92%: 53.3% for patients who received only antibiotic therapy and 38.7% for those who also had surgery. The median healing time was 13 weeks and ranged from 4 to 56 weeks. In the CDTUB of Allada, between 2010 and 2014, most patients were treated with antibiotic therapy alone, but a significant number still received surgery.